[144] TD SYNNEX CORP SEC Filing

Rhea-AI Filing Summary

SNX: A stockholder filed a Form 144 to sell up to 1,762 shares of common stock on the NYSE through Morgan Stanley Smith Barney, reflecting an aggregate market value of $272,321.99, with an approximate sale date of 10/21/2025.

The seller’s recent acquisitions include 1,329 shares as restricted stock on 10/15/2025 and purchases via the employee stock purchase plan of 219 shares on 12/31/2024 and 214 shares on 06/30/2025. Shares outstanding were 81,437,855. In the past three months, a reported sale of 1,257 shares generated gross proceeds of $179,015.53.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1762	272321.99	81437855	10/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/15/2025	Restricted Stock	Issuer			1329	10/15/2025	Not Applicable
Common	12/31/2024	Employee Stock Purchase Plan	Issuer			219	12/31/2024	Cash
Common	06/30/2025	Employee Stock Purchase Plan	Issuer			214	06/30/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ALIM DHANJI 44201 Nobel Drive Fremont CA 94538	Common	07/22/2025	1257	179015.53

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did SNX disclose in this Form 144?

A proposed sale of up to 1,762 shares of SNX common stock on the NYSE with an aggregate market value of $272,321.99 and an approximate sale date of 10/21/2025.

Which broker is named for the SNX Form 144 sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker.

How many SNX shares are outstanding per the filing?

Shares outstanding were 81,437,855.

What recent SNX share acquisitions does the filer report?

Restricted stock of 1,329 shares on 10/15/2025, ESPP purchases of 219 shares on 12/31/2024 and 214 shares on 06/30/2025.

Were there sales in the past three months related to SNX?

Yes. A reported sale of 1,257 shares on 07/22/2025 produced gross proceeds of $179,015.53.

On which exchange will the SNX shares be sold?

The filing names the NYSE.

What is the aggregate market value of the proposed SNX sale?

The aggregate market value is $272,321.99 for 1,762 shares.